Skip to Content
Merck
  • Folic Acid Rescues Valproic Acid-Induced Morphogenesis Inhibition in Neural Rosettes Derived From Human Pluripotent Stem Cells.

Folic Acid Rescues Valproic Acid-Induced Morphogenesis Inhibition in Neural Rosettes Derived From Human Pluripotent Stem Cells.

Frontiers in cellular neuroscience (2022-06-03)
Xiao-Zuo Zhang, Hai-Qin Huo, Yu-Qing Zhu, Hao-Yang Feng, Jiao Jiao, Jian-Xin Tan, Yan Wang, Ping Hu, Zheng-Feng Xu
ABSTRACT

The ability of human pluripotent stem cells (hPSCs) to specialize in neuroepithelial tissue makes them ideal candidates for use in the disease models of neural tube defects. In this study, we cultured hPSCs in suspension with modified neural induction method, and immunostaining was applied to detect important markers associated with cell fate and morphogenesis to verify the establishment of the neural tube model in vitro. We carried out the drug experiments to further investigate the toxicity of valproic acid (VPA) exposure and the potential protective effect of folic acid (FA). The results demonstrated that neural rosette undergoes cell fate speciation and lumen formation accompanied by a spatiotemporal shift in the expression patterns of cadherin, indicating the model was successfully established. The results showed that VPA caused morphogenesis inhibition of lumen formation by altering cytoskeletal function and cell polarization, which could be rescued by FA supplement.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Ezrin antibody produced in mouse, clone 3C12, ascites fluid
Sigma-Aldrich
QuantiPro BCA Assay Kit, for 0.5-30 μg/ml protein
Sigma-Aldrich
Anti-phospho Histone H3.1 (Ser28), clone 5D10D4 Antibody, clone 5D10D4, from rat
Roche
cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail, Tablets provided in EASYpacks